ADSK vs VRTX · P/E 65, rev $3.98B vs P/E 30, rev $3.33B
Autodesk Inc (ADSK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Autodesk Inc (ADSK) is a software - application company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ADSK revenue for 2026-07-31 was $3.98B. Net income was $983.0M. ADSK currently screens at market cap $67.33B and trailing P/E 65.4.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ADSK currently screens at market cap $67.33B and trailing P/E 65.4. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ADSK and VRTX stock pages for the full models.
Not investment advice.